CONVERT PHARMACEUTICALS
Organisation
Private Company
Belgium
LIEGE
,
Belgium
CONVERT PHARMACEUTICALS
1
Projects
0
Interests Submitted
903132566
PIC
903132566
Reference
Projects
TUMAGNOSTIC
A disruptive hypoxia activated prodrug for the treatment of resistant cancers: an AI-driven approach
HORIZON
Signed
HORIZON-EIC-2023-ACCELERATOR-01
Work Programmes
HORIZON
Additional Information
VAT:
BE0671828631
Validation Status:
31042522